Yorktown Management & Research CO Inc Acadia Pharmaceuticals Inc Transaction History
Yorktown Management & Research CO Inc
- $115 Million
- Q3 2025
A detailed history of Yorktown Management & Research CO Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Yorktown Management & Research CO Inc holds 12,050 shares of ACAD stock, worth $263,292. This represents 0.22% of its overall portfolio holdings.
Number of Shares
12,050
Previous 12,050
-0.0%
Holding current value
$263,292
Previous $259,000
0.77%
% of portfolio
0.22%
Previous 0.27%
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
354Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$937 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$264 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$197 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$135 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.54B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...